These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33034910)

  • 1. The performance of the chemiluminescent immunoassay for measuring serum myeloperoxidase and proteinase 3 antibodies.
    Hou X; Liu J; Wang T; Zhou J; Cui L
    J Clin Lab Anal; 2021 Feb; 35(2):e23615. PubMed ID: 33034910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
    Csernok E; Ahlquist D; Ullrich S; Gross WL
    Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China.
    Chang DY; Li ZY; Chen M; Zhao MH
    Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of enzyme-linked immunosorbent assay and rapid chemiluminescent analyser in the detection of myeloperoxidase and proteinase 3 autoantibodies.
    Pucar PA; Hawkins CA; Randall KL; Li C; McNaughton E; Cook MC
    Pathology; 2017 Jun; 49(4):413-418. PubMed ID: 28549721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
    Bornstein G; Ben-Zvi I; Furie N; Grossman C
    Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies.
    Bossuyt X; Rasmussen N; van Paassen P; Hellmich B; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Csernok E; Damoiseaux J
    Rheumatology (Oxford); 2017 Sep; 56(9):1533-1541. PubMed ID: 28541581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays.
    Damoiseaux J; Csernok E; Rasmussen N; Moosig F; van Paassen P; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Bossuyt X
    Ann Rheum Dis; 2017 Apr; 76(4):647-653. PubMed ID: 27481830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis.
    Walker BS; Peterson LK; Koening C; White SK; Schmidt RL; Tebo AE
    Autoimmun Rev; 2022 Jun; 21(6):103100. PubMed ID: 35452854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies.
    Mahler M; Radice A; Yang W; Bentow C; Seaman A; Bianchi L; Sinico RA
    Clin Chim Acta; 2012 Apr; 413(7-8):719-26. PubMed ID: 22265712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
    Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
    Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verification, implementation and harmonization of automated chemiluminescent immunoassays for MPO- and PR3-ANCA detection.
    Ogrič M; Švec T; Poljšak KM; Žigon P; Hočevar A; Čučnik S
    Clin Chem Lab Med; 2024 Mar; 62(4):682-689. PubMed ID: 37870064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel strategy with combined assays for detection of anti-neutrophil cytoplasmic antibody (ANCA) in clinically ANCA-negative granulomatosis with polyangiitis patients.
    Tateyama K; Kodama S; Kishibe K; Harabuchi Y; Suzuki M
    Auris Nasus Larynx; 2017 Dec; 44(6):735-741. PubMed ID: 28666565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan.
    Ono N; Niiro H; Ueda A; Sawabe T; Nishizaka H; Furugo I; Yoshizawa S; Yoshizawa S; Tsukamoto H; Kiyohara C; Tada Y; Horiuchi T
    Rheumatol Int; 2015 Mar; 35(3):555-9. PubMed ID: 25129031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic loci of Staphylococcus aureus associated with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides.
    Glasner C; de Goffau MC; van Timmeren MM; Schulze ML; Jansen B; Tavakol M; van Wamel WJB; Stegeman CA; Kallenberg CGM; Arends JP; Rossen JW; Heeringa P; van Dijl JM
    Sci Rep; 2017 Sep; 7(1):12211. PubMed ID: 28939882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.